In 1980, the physician James Fries published a paper in The New England Journal of Medicine with an awkward title and an elegant idea. The paper was called "Aging, natural death, and the compression of morbidity." It proposed that the goal of medicine should not be to extend life indefinitely but to compress the period of late-life disease into as short a window as possible.
The paper has been cited tens of thousands of times. The framework it introduced remains, forty-five years later, the right way to think about what the longevity project is actually for.
The Fries thesis
Fries observed two trends. Life expectancy had risen substantially over the previous century, primarily through reductions in infant mortality and infectious disease. But maximum human lifespan had not changed. The oldest people in his data were dying at roughly the same ages as the oldest people in earlier eras. The species ceiling, whatever its mechanism, appeared stable.
He proposed that the relevant goal was not to push the ceiling further but to reduce the period of morbidity that precedes it. If the average person dies around 85 and spends the last fifteen years in declining health, the longevity intervention worth wanting is not to add years on the end but to subtract years from the period of decline. Live well for as long as possible, decline rapidly, die.
The shape Fries had in mind is the "rectangularisation" of the survival curve: the area under the curve representing morbidity gets squeezed into a shorter and shorter interval as healthspan expands toward lifespan.
Lifespan versus healthspan
The two words sound similar enough that the distinction is often blurred in the popular discourse. They are different in important ways.
Lifespan is the number of years a person lives. It is easy to measure and the relevant endpoint for actuaries. It is also a poor proxy for what most people actually want, which is not more years but more years of being themselves.
Healthspan is the number of years a person lives in good functional health — mobile, cognitively intact, capable of doing the things that constitute their life. It is harder to measure, requires defining "good health," and varies meaningfully by population and individual. It is the endpoint that matches what people are usually trying to optimise for when they say they want to live longer.
The gap between lifespan and healthspan in developed countries currently runs around 8–12 years. Most of that gap is occupied by chronic disease that did not need to happen on the timeline it did.
What separates a sharp 80-year-old from a declining one
Centenarian and "super-ager" research has been clarifying on this point. The eighty-year-olds who function like sixty-year-olds — the ones who walk briskly, think clearly, recognise their grandchildren, live independently — tend to share a recognisable pattern of upstream variables.
The clearest signals:
- Cardiorespiratory fitness. VO2 max declines with age, but the trajectory is heavily modifiable. A fit eighty-year-old often has the aerobic capacity of an unfit fifty-year-old. The functional gap this produces is enormous.
- Muscle mass and strength. Sarcopenia — age-related muscle loss — is one of the most predictable trajectories of decline and one of the most modifiable. Resistance-trained octogenarians retain function and independence that untrained ones lose.
- Metabolic health. Stable glucose regulation, normal blood pressure, reasonable lipid profiles. The absence of metabolic disease is more important than the presence of any particular intervention.
- Cognitive engagement. Sustained intellectual activity, social connection, and a sense of purpose track reasonably well with cognitive preservation. The mechanism is mixed (cognitive reserve, vascular factors, social cortisol modulation) but the association is robust.
- Sleep. The sleep architecture of late life predicts cognitive decline over the following decade more strongly than most other biomarkers.
None of these are exotic. None of them require a supplement subscription. All of them require sustained investment over decades, which is the reason most people do not have them.
What is actually modifiable
Of the major drivers of late-life decline, the modifiable share is large.
Cardiovascular disease, type 2 diabetes, most cancers, and a substantial proportion of dementia cases are partially or largely lifestyle-driven, on timescales measured in decades rather than weeks. The interventions are the unspectacular ones: regular exercise of both modalities, adequate sleep, reasonable diet, low chronic stress, social connection, low to moderate alcohol intake, no smoking. These appear repeatedly in cohort studies of healthy ageing because they are the things that matter.
The interventions that get more media attention — specific supplements, novel drugs, hormone optimisation, cold plunges, sauna protocols — sit somewhere on the spectrum from "modest plausible benefit" to "interesting in mice." None of them substitute for the basics. Several of them serve as a way of avoiding the basics.
Why this is the right frame
Talk of "anti-ageing" or "life extension" sets up an adversarial relationship with biology that no one is going to win. The cellular machinery of senescence is robust and ancient. It will not be reversed by a molecule discovered in the last decade. It will not be defeated by an app.
But the gap between the lifespan people will get and the healthspan they could have is enormous, well-characterised, and largely the product of choices accumulated over decades. Closing that gap is not a moonshot. It is a long, unglamorous project of doing things that are mostly already known.
"It is the quality of life rather than the length of life that has become the social challenge of the next decades." — James Fries, 1980.
Fries was right then. The framing has aged better than most of the alternatives that came along to replace it.
